source
- Sanofi CEO pledges to rebuild trust and expand partnership with RegeneronSanofi's new chief executive, Belén Garijo, told analysts that restoring the relationship with longtime partner Regeneron is a top priority. She said the company wants to be more transparent and to…
- Novo setback casts doubt on a new way to treat heart diseaseZiltivekimab's failure in a key trial hurt spurred share sell-offs for Novo and other biotechs, as it suggested trouble for different cardiovascular drugs that also target inflammation.BioPharma Dive · 24m ago↗ source
- Alnylam shares tumble nearly 30% after cutting revenue outlook for key amyloidosis drugs